Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1745-1752

  Huppler, Anna R ^a,b   Conti, Heather R ^b   Hernández Santos, Nydiaris ^b   Darville, Toni ^a   Biswas, Partha S ^b   Gaffen, Sarah L ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; ANTIGENS, LY; CANDIDA ALBICANS; CANDIDIASIS, ORAL; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOUTH MUCOSA; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-8B; TH17 CELLS;

EID: 84894270649     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302265     Document Type: Article

References (49)

1. Antachopoulos, C., T. J. Walsh, and E. Roilides. 2007. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr. 166: 1099-1117.
2. Farah, C. S., N. Lynch, and M. J. McCullough. 2010. Oral fungal infections: an update for the general practitioner. Aust. Dent. J. 55(Suppl. 1): 48-54.
3. Huppler, A. R., S. Bishu, and S. L. Gaffen. 2012. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res. Ther. 14: 217.
4. Conti, H. R., F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206: 299-311.
5. Milner, J. D., J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill, K. M. Elias, Y. Kanno, C. Spalding, H. Z. Elloumi, M. L. Paulson, et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
6. Gaffen, S. L., N. Hernández-Santos, and A. C. Peterson. 2011. IL-17 signaling in host defense against Candida albicans. Immunol. Res. 50: 181-187.
7. van de Veerdonk, F. L., M. S. Gresnigt, B. J. Kullberg, J. W. van der Meer, L. A. Joosten, and M. G. Netea. 2009. Th17 responses and host defense against microorganisms: an overview. BMB Rep. 42: 776-787.
8. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
9. Ho, A. W., F. Shen, H. R. Conti, N. Patel, E. E. Childs, A. C. Peterson, N. Hernández-Santos, J. K. Kolls, L. P. Kane, W. Ouyang, and S. L. Gaffen. 2010. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J. Immunol. 185: 1063-1070.
10. Saunus, J. M., S. A. Wagner, M. A. Matias, Y. Hu, Z. M. Zaini, and C. S. Farah. 2010. Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis. Mol Oral Microbiol. 25: 343-356.
11. Puel, A., S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
12. Boisson, B., C. Wang, V. Pedergnana, L. Wu, S. Cypowyj, M. Rybojad, A. Belkadi, C. Picard, L. Abel, C. Fieschi, et al. 2013. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39: 676-686.
13. Koh, A. Y., J. R. Köhler, K. T. Coggshall, N. Van Rooijen, and G. B. Pier. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4: e35.
14. Concia, E., A. M. Azzini, and M. Conti. 2009. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 69(Suppl. 1): 5-14.
15. Del Favero, A. 2000. Management of fungal infections in neutropenic patients: more doubts than certainties? Int. J. Antimicrob. Agents 16: 135-137.
16. Welte, K., C. Zeidler, and D. C. Dale. 2006. Severe congenital neutropenia. Semin. Hematol. 43: 189-195.
17. Lanza, F. 1998. Clinical manifestation of myeloperoxidase deficiency. J. Mol. Med. (Berl). 76: 676-681.
18. Rot, A., and U. H. von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22: 891-928.
19. Cacalano, G., J. Lee, K. Kikly, A. M. Ryan, S. Pitts-Meek, B. Hultgren, W. I. Wood, and M. W. Moore. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265: 682-684.
20. Reutershan, J., M. A. Morris, T. L. Burcin, D. F. Smith, D. Chang, M. S. Saprito, and K. Ley. 2006. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116: 695-702.
21. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R7-R28.
22. Mei, J., Y. Liu, N. Dai, C. Hoffmann, K. M. Hudock, P. Zhang, S. H. Guttentag, J. K. Kolls, P. M. Oliver, F. D. Bushman, and G. S. Worthen. 2012. Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J. Clin. Invest. 122: 974-986.
23. Murdoch, C., P. N. Monk, and A. Finn. 1999. Cxc chemokine receptor expression on human endothelial cells. Cytokine 11: 704-712.
24. Frazer, L. C., C. M. O'Connell, C. W. Andrews, Jr., M. A. Zurenski, and T. Darville. 2011. Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect. Immun. 79: 4029-4041.
25. Wozniak, K. L., J. K. Kolls, and F. L. Wormley, Jr. 2012. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells. BMC Immunol. 13: 65.
26. Mehrad, B., R. M. Strieter, T. A. Moore, W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163: 6086-6094.
27. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
28. Kamai, Y., M. Kubota, Y. Kamai, T. Hosokawa, T. Fukuoka, and S. G. Filler. 2001. New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemother. 45: 3195-3197.
29. Eash, K. J., A. M. Greenbaum, P. K. Gopalan, and D. C. Link. 2010. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120: 2423-2431.
30. Shen, F., and S. L. Gaffen. 2008. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41: 92-104.
31. Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.
32. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
33. Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of TH17 cells. Semin. Immunol. 19: 383-393.
34. Serafini, P., R. Carbley, K. A. Noonan, G. Tan, V. Bronte, and I. Borrello. 2004. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64: 6337-6343.
35. Bronte, V., E. Apolloni, A. Cabrelle, R. Ronca, P. Serafini, P. Zamboni, N. P. Restifo, and P. Zanovello. 2000. Identification of a CD11b(+)/Gr-1(+)/ CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96: 3838-3846.
36. Mencacci, A., C. Montagnoli, A. Bacci, E. Cenci, L. Pitzurra, A. Spreca, M. Kopf, A. H. Sharpe, and L. Romani. 2002. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169: 3180-3190.
37. Stadtmann, A., and A. Zarbock. 2012. CXCR2: from bench to bedside. Front. Immunol. 3: 263.
38. Bonnett, C. R., E. J. Cornish, A. G. Harmsen, and J. B. Burritt. 2006. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect. Immun. 74: 6528-6539.
39. Schuh, J. M., K. Blease, and C. M. Hogaboam. 2002. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J. Immunol. 168: 1447-1456.
40. Ngo, L. Y., S. Kasahara, D. K. Kumasaka, S. E. Knoblaugh, A. Jhingran, and T. M. Hohl. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209: 109-119.
41. Ermert, D., M. J. Niemiec, M. Röhm, A. Glenthøj, N. Borregaard, and C. F. Urban. 2013. Candida albicans escapes from mouse neutrophils. J. Leukoc. Biol. 94: 223-236.
42. Conti, H. R., O. Baker, A. F. Freeman, W. S. Jang, S. M. Holland, R. A. Li, M. Edgerton, and S. L. Gaffen. 2011. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol. 4: 448-455.
43. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377-382.
44. Farah, C. S., S. Elahi, G. Pang, T. Gotjamanos, G. J. Seymour, R. L. Clancy, and R. B. Ashman. 2001. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69: 6110-6118.
45. Mamishi, S., S. A. Esfahani, N. Parvaneh, J. Diestelhorst, and N. Rezaei. 2009. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J. Investig. Allergol. Clin. Immunol. 19: 500-503.
46. Leonardi, C., R. Matheson, C. Zachariae, G. Cameron, L. Li, E. Edson-Heredia, D. Braun, and S. Banerjee. 2012. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366: 1190-1199.
47. Papp, K. A., C. Leonardi, A. Menter, J. P. Ortonne, J. G. Krueger, G. Kricorian, G. Aras, J. Li, C. B. Russell, E. H. Thompson, and S. Baumgartner. 2012. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366: 1181-1189.
48. Patel, D. D., D. M. Lee, F. Kolbinger, and C. Antoni. 2013. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann. Rheum. Dis. 72(Suppl. 2): ii116-ii123.
49. Ford, A. C., and L. Peyrin-Biroulet. 2013. Opportunistic infections with antitumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. Am. J. Gastroenterol. 108: 1268-1276.